Cargando…

17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells

A significant proportion of the genes regulated by 17-beta-estradiol (E2) via estrogen receptor alpha (ERα) have roles in vesicle trafficking in breast cancer. Intracellular vesicle trafficking and extracellular vesicles have important roles in tumourigenesis. Here we report the discovery of giant (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Paul K, Jones, Sarah Bowen, Ardern, Nicholas, Ward, Rebecca, Clarke, Robert B, Sotgia, Federica, Lisanti, Michael P, Landberg, Goran, Lamb, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102791/ https://www.ncbi.nlm.nih.gov/pubmed/24931391

Ejemplares similares

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment
por: Ward, Rebecca, et al.
Publicado: (2015)

Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer
por: Lamb, Rebecca, et al.
Publicado: (2014)

During development, 17alpha-estradiol is a potent estrogen and carcinogen.
por: Hajek, R A, et al.
Publicado: (1997)

Essential role of STAT5a in DCIS formation and invasion following estrogen treatment
por: Dees, Sundee, et al.
Publicado: (2020)

17β-Estradiol Prevents Early-Stage Atherosclerosis in Estrogen Receptor-Alpha Deficient Female Mice
por: Villablanca, Amparo C., et al.
Publicado: (2009)

Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol
por: Alyea, Rebecca A., et al.
Publicado: (2009)

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
por: Lamb, Rebecca, et al.
Publicado: (2014)

The effects of 17 alpha-estradiol to inhibit inflammation in vitro
por: Santos, Roberta S., et al.
Publicado: (2017)

Modulation of uterine morphology and growth by estradiol-17beta and an estrogen antagonist
Publicado: (1975)

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
por: Lamb, Rebecca, et al.
Publicado: (2015)

17β-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy
por: Fang, Hsin-Yuan, et al.
Publicado: (2018)

The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy
por: Fiorillo, Marco, et al.
Publicado: (2018)

Associations of serum estradiol level, serum estrogen receptor-alpha level, and estrogen receptor-alpha polymorphism with male infertility: A retrospective study
por: Luo, Hongcheng, et al.
Publicado: (2021)

The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane
por: Acconcia, Filippo, et al.
Publicado: (2011)

Neuroprotective Effects of 17β-Estradiol Rely on Estrogen Receptor Membrane Initiated Signals
por: Fiocchetti, Marco, et al.
Publicado: (2012)

Quantum Dot-Sensitised Estrogen Receptor-α-Based Biosensor for 17β-Estradiol
por: Jijana, Abongile N., et al.
Publicado: (2023)

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
por: Fiorillo, Marco, et al.
Publicado: (2016)

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
por: Lamb, Rebecca, et al.
Publicado: (2015)

Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy
por: Sotgia, Federica, et al.
Publicado: (2017)

Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine
por: Sotgia, Federica, et al.
Publicado: (2017)

Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics
por: Sotgia, Federica, et al.
Publicado: (2017)

Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner
por: Sotgia, Federica, et al.
Publicado: (2020)

Effects of 17β-Estradiol and Estrogen Receptor Antagonists on the Proliferation of Gastric Cancer Cell Lines
por: Kim, Myung-Jin, et al.
Publicado: (2013)

INVESTIGATING THE NEURAL AFFECTS OF 17 ALPHA-ESTRADIOL (17Α-E2) ON APOE4 PHENOTYPES
por: Roache, Tavia, et al.
Publicado: (2022)

Estrogen Receptor Alpha Polymorphisms, Estradiol Level, and Occurrence of Atherosclerosis Risk Factors in Healthy Postmenopausal Women
por: Bojar, Iwona, et al.
Publicado: (2015)

Evidence that 17alpha-estradiol is biologically active in the uterine tissue: Antiuterotonic and antiuterotrophic action
por: Perusquía, Mercedes, et al.
Publicado: (2005)

High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
por: Farnie, Gillian, et al.
Publicado: (2015)

Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs)
por: Ozsvari, Bela, et al.
Publicado: (2018)

A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis
por: Ozsvari, Bela, et al.
Publicado: (2017)

Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
por: Sotgia, Federica, et al.
Publicado: (2017)

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways
por: Bonuccelli, Gloria, et al.
Publicado: (2018)

Hallmarks of the cancer cell of origin: Comparisons with “energetic” cancer stem cells (e-CSCs)
por: Sotgia, Federica, et al.
Publicado: (2019)

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
por: Fiorillo, Marco, et al.
Publicado: (2019)

First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds
por: Ózsvári, Béla, et al.
Publicado: (2020)

COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
por: Sargiacomo, Camillo, et al.
Publicado: (2020)

Identification of natural products and FDA-approved drugs for targeting cancer stem cell (CSC) propagation
por: Bonuccelli, Gloria, et al.
Publicado: (2022)

Lysosomal Function Is Involved in 17β-Estradiol-Induced Estrogen Receptor α Degradation and Cell Proliferation
por: Totta, Pierangela, et al.
Publicado: (2014)

17β-estradiol lowers triglycerides in adipocytes via estrogen receptor α and it may be attenuated by inflammation
por: Luo, Fei, et al.
Publicado: (2017)

The Role of 17β-Estradiol and Estrogen Receptors in Regulation of Ca(2+) Channels and Mitochondrial Function in Cardiomyocytes
por: Mahmoodzadeh, Shokoufeh, et al.
Publicado: (2019)

Estrogen modulation of pain perception with a novel 17β-estradiol pretreatment regime in ovariectomized rats
por: Zhang, Wenxin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ar6dsmhpaef0bmqoqudd2rjffg